JPRN-UMIN000022024招募中未知
Exploratory study about the effect of silodosin on female voiding dysfunction - Exploratory study about the effect of silodosin on female voiding dysfunction
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1)severe heart disease 2)severe liver diseae or over 3mg/dl total bilirubin or over 2.5 times AST(GOT)o ALT(GPT) 3)severe kidney disease or over 1.5mg/dl creatinine 4)severe hypotention 5)women who are pregnant, breast-feeding, or seeking to conceive or may conceive due to improper contraception method during the study period 6)Patients receiving surgical therapy, which may influence the lower urinary tract function 7)Patients receiving nonpharmacologic therapy within 4 weeks prior to the study commencement, which may influence the lower urinary tract function 8)Patients who received an investigational drug in other clinical study within 1 month prior to the study commencement (the period of which should be calculated based on the date on which the investigational drug was administered) 9)Patients who are otherwise ineligible to take part in the study as judged by Principal Investigator or other relevant person
研究者
相似试验
进行中（未招募）
1 期
A clinical study, which evaluates the effectiveness and the safety of a new medication for prostatic hyperplasia, silodosin, when administered under normal conditions of use in a wide European population.EUCTR2011-000045-20-ESRECORDATI S.p.A
进行中（未招募）
1 期
Effectiveness and safety of silodosin in the treatment of patients with benign prostatic hyperplasia.Benign prostatic hyperplasia.EUCTR2011-000045-20-RORECORDATI S.p.A
进行中（未招募）
不适用
Effectiveness and safety of silodosin in the treatment of LUTS in patients with benign prostatic hyperplasia: a European phase IV clinical study (the Silodosin in Real-life Evaluation study) - SIREBenign prostatic hyperplasia.MedDRA version: 13.1Level: PTClassification code 10004446Term: Benign prostatic hyperplasiaSystem Organ Class: 10038604 - Reproductive system and breast disordersEUCTR2011-000045-20-HURECORDATI S.p.A1,000
进行中（未招募）
不适用
A clinical study, which evaluates the effectiveness and the safety of a new medication for prostatic hyperplasia, silodosin, when administered under normal conditions of use in a wide European population.EUCTR2011-000045-20-PTRECORDATI S.p.A1,000
进行中（未招募）
不适用
A clinical study, which evaluates the effectiveness and the safety of a new medication for prostatic hyperplasia, silodosin, when administered under normal conditions of use in a wide European population.EUCTR2011-000045-20-DERECORDATI S.p.A1,000